TWP
ABBV icon

Tower Wealth Partners’s AbbVie ABBV Stock Holding History

Tower Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$445K Buy
1,770
+177
+11% +$38.1K 0.22% 54
2026
Q1 		$346K Buy
1,593
+1
+0.1% +$222 0.19% 57
2025
Q4 		$364K Buy
1,592
+23
+1% +$5.24K 0.2% 55
2025
Q3 		$363K Buy
1,569
+32
+2% +$6.52K 0.2% 56
2025
Q2 		$285K Buy
1,537
+51
+3% +$9.48K 0.17% 62
2025
Q1 		$311K Buy
1,486
+73
+5% +$14.2K 0.17% 54
2024
Q4 		$251K Sell
1,413
-13
-0.9% -$2.39K 0.13% 60
2024
Q3 		$282K Buy
1,426
+11
+0.8% +$2.05K 0.16% 53
2024
Q2 		$243K Buy
1,415
+195
+16% +$32.3K 0.15% 56
2024
Q1 		$222K Buy
+1,220
New +$210K 0.14% 56

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tower Wealth Partners's ABBV Position: Q2 2026 in Review

Tower Wealth Partners increased its AbbVie (ABBV) stake by 11% in Q2 2026, buying an estimated $38.1K and bringing the position to 1,770 shares worth $445K. The position accounts for 0.22% of the portfolio, ranked #54.

Tower Wealth Partners first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tower Wealth Partners held 1,770 shares of AbbVie worth $445K as of Q2 2026.
  • Tower Wealth Partners bought 177 AbbVie shares in Q2 2026, an estimated $38.1K.
  • AbbVie made up 0.22% of Tower Wealth Partners's portfolio in Q2 2026, its #54 holding.
  • Tower Wealth Partners first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tower Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.